Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118685794A reveals a green one-step electrochemical route for isoxazoline compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Grignard-based route for bis(3-furyl)phosphorus chloride offers high yield and mild conditions. Reliable supply chain partner for pharmaceutical ligand intermediates.
Patent CN102911229B reveals a greener synthesis route for Cytidine using polymer-supported catalysts, offering significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Patent CN104926704B reveals a mild light-induced route for aziridine intermediates. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced enzymatic and chemical separation process for high-purity escitalopram intermediates. Reduces manufacturing costs and improves supply chain reliability for global API producers.
Patent CN116003294A reveals a novel 3-step synthesis for 2-bromo-6-chlorobenzonitrile. Achieve high purity and stable yields with reduced operational costs for pharmaceutical manufacturing.
Patent CN107573285B enables high-purity quinolinone synthesis via Pd-catalyzed decarboxylative cycloaddition, offering cost reduction and scalable supply chain solutions.
Patent CN113214112A reveals a mild, base-catalyzed route for beta-amino acrylate substituted acetonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel intermediates and methods for CPT-11 and mappicine synthesis offering improved yield and chiral control for pharmaceutical manufacturing supply chains.
Patent CN108587991A reveals novel aminotransferase and isomerase pairs for L-allo-Ile production. Discover green enzymatic methods for high-purity pharmaceutical intermediates and cost reduction.
Patent CN101186944B details enzymatic hydrolysis for chiral amino acids. Offers cleaner production and scalable supply chain solutions for pharmaceutical intermediates.
Novel TEMPO-catalyzed oxidative cyclization for 1,2,3,4-tetrahydrocinnoline scaffolds. Mild conditions, high yields, scalable process for anticancer drug development.
Patent CN115948360A details an imine reductase mutant achieving >99.5% conversion and 99.6% ee for nicotine analog intermediates, offering significant cost and supply chain advantages.
Patent CN104630125B reveals engineered E. coli for high-purity statin intermediate synthesis with mild conditions and reduced processing complexity.
Patent CN109837317B details a novel enzymatic method for synthesizing high-purity chiral alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel patent CN115417776B offers high-yield 2-amino-1-propanol synthesis. Reduces waste and cost for pharmaceutical intermediates supply chain reliability.
Patent CN105001085B reveals layered catalyst method. High purity, recyclable catalyst, cost reduction in agrochemical intermediate manufacturing.
Patent CN119998301A reveals a cost-effective synthesis route for pharmaceutical intermediates. Enhanced supply chain reliability and high-purity output for global buyers.
Novel synthesis route for pharmaceutical intermediates reduces costs and improves scalability. Reliable supply chain for high-purity boronic acid derivatives.
Patent CN101547893B reveals a novel salt recovery method for biphenylalanine, enabling cost reduction in pharmaceutical intermediate manufacturing through direct extraction and recycling.